Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
203M
-
Number of holders
-
182
-
Total 13F shares, excl. options
-
79.2M
-
Shares change
-
+4.3M
-
Total reported value, excl. options
-
$2.26B
-
Value change
-
+$130M
-
Put/Call ratio
-
0.3
-
Number of buys
-
90
-
Number of sells
-
-98
-
Price
-
$28.51
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q3 2024
243 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.2M shares
of 203M outstanding shares and own 39.07% of the company stock.
Largest 10 shareholders include FMR LLC (12.5M shares), VANGUARD GROUP INC (6.66M shares), BlackRock, Inc. (5.05M shares), Deep Track Capital, LP (4.35M shares), ARMISTICE CAPITAL, LLC (3.55M shares), T. Rowe Price Investment Management, Inc. (3.33M shares), STATE STREET CORP (3.02M shares), PERCEPTIVE ADVISORS LLC (2.38M shares), VIKING GLOBAL INVESTORS LP (2.32M shares), and Alpine Global Management, LLC (1.88M shares).
This table shows the top 182 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.